Ronald Eisenstein, a member of  Nixon Peabody LLP life sciences team, prosecutes, counsels and litigates matters specifically regarding patents, portfolios and due diligence. Eisenstein has represented mostly research institutions and medical institutions on a variety of patent-related matters, and his work has been seen across multiple jurisdictions, notably across Europe and in front of the WIPO.
Legal 500 Editorial commentary

Accolades

Boston Elite